- Home
- PACB vs NXP Comparison
PACB vs NXP Comparison
Compare PACB & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PACB | NXP |
|---|---|---|
| Founded | 2000 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 715.5M | 743.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PACB | NXP |
|---|---|---|
| Price | $2.13 | $14.28 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 8.6M | 70.0K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $154,584,000.00 | N/A |
| Revenue This Year | $4.41 | N/A |
| Revenue Next Year | $11.76 | N/A |
| P/E Ratio | ★ N/A | $26.81 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.85 | $12.91 |
| 52 Week High | $2.73 | $14.89 |
Technical Indicators
Market Signals| Indicator | PACB | NXP |
|---|---|---|
| Relative Strength Index (RSI) | 49.91 | 44.76 |
| Support Level | $2.30 | $14.23 |
| Resistance Level | $2.47 | $14.38 |
| Average True Range (ATR) | 0.20 | 0.13 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 5.69 | 27.00 |
Price Performance
Historical ComparisonAbout PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
About NXP Nuveen Select Tax Free Income Portfolio
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.